Pulse application of platelet-derived growth factor enhances formation of a mineralizing matrix while continuous application is inhibitory.
Platelet-derived growth factor (PDGF) stimulates chemotaxis and proliferation of osteoblasts, and induces bone formation in vivo. To determine how PDGF might regulate these cells, the effect of PDGF on long-term mineralizing cultures of fetal rat osteoblastic cells was examined. Although PDGF increased cell proliferation in these cultures, continuous treatment with PDGF caused a dose-dependent decrease in mineralized nodule formation. When cells were treated with multiple, brief (1 day) exposures to PDGF at the osteoblast differentiation stage, there was a significant 50% increase in mineralized nodule area. Based on modulation of alkaline phosphatase activity it appears that longer-term exposure to PDGF reduces mineralized nodule formation largely by inhibiting differentiated osteoblast function, while short-term exposure enhances proliferation without inhibiting the differentiated phenotype. Thus, the ultimate affect of PDGF on bone formation is likely to reflect two processes: a positive effect through enhancing cell number or a negative effect by inhibiting differentiated function. The inhibitory effect of PDGF on formation of a mineralized matrix is unlikely to be simply a result of enhanced proliferation of "fibroblastic" cells since cultures treated with PDGF for 3 days and then transferred to new plastic dishes exhibited a 70% increase in mineralized nodule area compared to controls. These results would predict that multiple, brief exposures to PDGF would enhance bone formation in vivo, while prolonged exposure to PDGF, which is likely to occur in chronic inflammation, would inhibit differentiated osteoblast function and limit bone regeneration.
Hsieh
S C
SC
Department of Periodontology and Oral Biology, Boston University Goldman School of Dental Medicine, Massachusetts 02118, USA.
Graves
D T
DT
D000818:Animals; D001857:Bone Matrix / Q000187:drug effects* / Q000254:growth & development; D002113:Calcification, Physiologic / Q000187:drug effects*; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D019281:Dimerization; D004305:Dose-Response Relationship, Drug; D005333:Fetus; D010006:Osteoblasts / Q000166:cytology / Q000378:metabolism; D010982:Platelet-Derived Growth Factor / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D012886:Skull; D013997:Time Factors
D010982:Platelet-Derived Growth Factor